ARENA PHARMACEUTICALS INC (ARNA.O) Short interest rose 16.6 percent. The bears piled on to Arena as U.S. government advisors considered whether to back the company's weight-loss pill, a crucial drug for the company. Advisors ultimately rejected the proposed pill on concerns tumors in rats might indicate a risk of cancer in humans
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.